1. Home
  2. AREC vs PROF Comparison

AREC vs PROF Comparison

Compare AREC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Resources Corporation

AREC

American Resources Corporation

HOLD

Current Price

$2.20

Market Cap

247.1M

Sector

Energy

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.73

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AREC
PROF
Founded
2013
N/A
Country
United States
Canada
Employees
7
N/A
Industry
Coal Mining
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
243.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AREC
PROF
Price
$2.20
$6.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$6.50
$12.00
AVG Volume (30 Days)
3.4M
51.3K
Earning Date
06-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
0.19
Revenue
N/A
$16,098,000.00
Revenue This Year
N/A
$92.40
Revenue Next Year
$38,462.50
$64.10
P/E Ratio
N/A
$35.00
Revenue Growth
N/A
50.73
52 Week Low
$0.77
$3.92
52 Week High
$7.11
$8.95

Technical Indicators

Market Signals
Indicator
AREC
PROF
Relative Strength Index (RSI) 47.11 48.77
Support Level $1.96 $6.47
Resistance Level $2.53 $7.06
Average True Range (ATR) 0.21 0.26
MACD -0.02 -0.01
Stochastic Oscillator 21.60 57.35

Price Performance

Historical Comparison
AREC
PROF

About AREC American Resources Corporation

American Resources Corp is engaged in the aggregation, recovery, recycling, and sale of recovered metal and steel materials. The company operates through two segments: Corporate and Electrified Materials. The Electrified Materials segment focuses on processing and recycling recovered metal and steel products.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: